Bausch Health Co. Inc. (BHC) Q3 Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Bausch Health Companies Inc. Announces Third-Quarter 2021 Results
November 2, 2021 6:59 AM EDTLAVAL, Quebec, Nov. 2, 2021 /PRNewswire/ --
Third-Quarter 2021 Financial Results Revenues of $2.111 Billion GAAP Net Income of $188 Million Adjusted EBITDA (non-GAAP)1Â of $885 Million GAAP Cash Generated from Operations of $564 MillionExpects to Launch Solta Medical IPO2 in December 2021 or January 2022 and Bausch + Lomb IPO Approximately 30 Days Following Solta Medical IPO3 Reaffirmed 2021 Full-Year Revenue and Adjusted EBITDA (non-GAAP) Guidance RangesBausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch... More
